Evidence map›Paper›PMID 33486637›Full record

Trial reportJournal of neuro-oncology2021

How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians.

Akanksha Sharma, Briant Fruth, Celina Barrera, Hannah N Farfour, Maciej M Mrugala, Mark K Edwin, Jeff A Sloan, Alyx B Porter

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04630379 (Pilot Study of Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04630379 nacompletednot on this map

Pilot Study of Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers

TypeinterventionalSponsorMayo ClinicRan2018 to 2020Enrolled16ConditionsGlioblastoma, Malignant Glioma, WHO Grade III GliomaArmsPalliative Therapy, Quality-of-Life Assessment, Supportive Care, Survey Administration
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Coping with primary brain tumors together: a scoping review of dyadic psychosocial interventions.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Distress in Neuro-Oncology Patients and Its Implications for Communication.Journal of the advanced practitioner in oncology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. High grade glioma and caregiver burden.Journal of neuro-oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Akanksha SharmaDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA. ekakanksha@gmail.com.ORCID http://orcid.org/0000-0002-4331-5526
Briant FruthDepartment of Biostatistics, Mayo Clinic, Rochester, MN, USA.
Celina BarreraDepartment of Palliative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Hannah N FarfourDepartment of Palliative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Maciej M MrugalaDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA.
Mark K EdwinDepartment of Palliative Medicine, Mayo Clinic, Phoenix, AZ, USA.
Jeff A SloanDepartment of Biostatistics, Mayo Clinic, Rochester, MN, USA.
Alyx B PorterDepartment of Neurology, Mayo Clinic, Phoenix, AZ, USA.
WinnMed · USMayo Clinic · USMayo Clinic Hospital · USSaint John's Health Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDiscordant prognostic awareness (PA) can cause distress, impact goals of care and future planning, especially in patients with high grade glioma (pwHGG) who have limited survival. We aimed to evaluate the feasibility of assessing PA of pwHGG, caregivers and clinicians using a single question and to evaluate these responses for discord, alignment and fluctuation over time.

methodsThis is a sub-study of an IRB-approved pilot study evaluating early palliative care and longitudinal symptom monitoring via a smart-device tool in 16 pwHGG and their caregivers receiving treatment at the Mayo Clinic Arizona (United States). Eligible patients were ≥ 18 years, English-speaking, newly-diagnosed, and had a willing caregiver. Participants answered a multiple-choice question asking for an estimate of their own or their loved one's survival on a monthly basis.

resultsAll except one patient/caregiver dyad answered the question each time it was asked. The question did not appear to cause discomfort or increase conversations with clinicians around prognosis. PA of patients and caregivers fluctuated monthly, ranging from dismal to overtly optimistic, with a discordance frequency of 68%. Patients tended to be more optimistic than caregivers, and a higher QOL correlated to a more optimistic response. Clinicians' were more hopeful; their prediction tended to fluctuate less than those of patients and caregivers.

conclusionsPA may be assessed in pwHGG and caregivers with a single, frank question. There is clear discordance between PA of patients, their caregivers and clinicians. Understanding fluctuates longitudinally through disease and treatment course. Additional studies on timing and ways of discussing prognosis in this population are needed. CLINICAL

trial registrationNCT04630379.

Indexed as

CaregiversComprehensionAdultAgedAged, 80 and overBrain NeoplasmsFeasibility StudiesFemaleGliomaHumansMaleMiddle AgedPilot ProjectsPrognosisQuality of LifeSurveys and QuestionnairesBrain tumorsCaregiversGlioblastomaGliomaPrognosisQuality of lifeTerminal disease

Identifiers

PMID33486637
OpenAlexW3123475198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.